ASX Announcements

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

DOCUMENT	RELEASED
Half Yearly Report and Accounts – 31 December 2018 - Market Sensitive	18 Feb 2019
Net Tangible Asset Backing – 31 January 2019	11 Feb 2019
episil added to the TGA register	5 Feb 2019
Net Tangible Asset Backing – 31 December 2018	4 Jan 2019

DOCUMENT	RELEASED
Net Tangible Asset Backing – 30 November 2018	4 Dec 2018
Net Tangible Asset Backing – 30 November 2018	3 Dec 2018
Results of Annual General Meeting 28 November 2018	28 Nov 2018
Chairman’s Address to Shareholders 2018	28 Nov 2018
BioImpact licenses episil for Australia and New Zealand	25 Nov 2018
Net Tangible Asset Backing – 31 October 2018	5 Nov 2018
Notice of Annual General Meeting/Proxy Form	26 Oct 2018
Net Tangible Asset Backing – 30 September 2018	3 Oct 2018
Net Tangible Asset Backing – 31 August 2018	6 Sep 2018
Annual Report to Shareholders 30 June 2018	21 Aug 2018
Appendix 4G 30 June 2018	21 Aug 2018
Appendix 4E and Financial Report 30 June 2018	21 Aug 2018
Change in substantial holding	9 Aug 2018
Net Tangible Asset Backing – 31 July 2018	7 Aug 2018
Net Tangible Asset Backing – 30 June 2018	10 Jul 2018
Net Tangible Asset Backing – 31 May 2018	6 Jun 2018
Final Director’s Interest Notice – Bruce Hancox	31 May 2018
Non-executive director retirement	31 May 2018
Net Tangible Asset Backing – 30 April 2018	1 May 2018
Change in substantial holding – Richard Treagus	20 Apr 2018
Change of Director’s Interest Notice – Richard Treagus	20 Apr 2018
Change of Director’s Interest Notice – Peter Jones	20 Apr 2018
Ceasing to be a substantial holder	20 Apr 2018
Final Director’s Interest Notice – Jennifer Herz	20 Apr 2018
Appendix 3B	20 Apr 2018
Results of Extraordinary General Meeting 17 April 2018	17 Apr 2018
Net Tangible Asset Backing – 31 March 2018	3 Apr 2018
Notice of Extraordinary General Meeting/Proxy Form	16 Mar 2018
Net Tangible Asset Backing – 28 February 2018	8 Mar 2018
Half Yearly Report and Accounts – 31 December 2017	26 Feb 2018
Change in substantial holding	7 Feb 2018
Net Tangible Asset Backing – 31 January 2018	5 Feb 2018
Perisolv dental product added to the ARTG	2 Feb 2018
Proposed Divestment of Biointelect	22 Jan 2018
Carisolv dental product added to the ARTG	8 Jan 2018
Net Tangible Asset Backing – 31 December 2017	3 Jan 2018

DOCUMENT	RELEASED
Ceasing to be a substantial holder	19 Dec 2017
Net Tangible Asset Backing – 30 November 2017	4 Dec 2017
Change of Director’s Interest Notice – Jennifer Herz	1 Dec 2017
Change of Director’s Interest Notice – Peter Jones	30 Nov 2017
Change of Director’s Interest Notice – Richard Treagus	30 Nov 2017
Appendix 3B	30 Nov 2017
Appendix 3B	30 Nov 2017
Results of Annual General Meeting 28 November 2017	28 Nov 2017
Chairman’s Address to Shareholders 2017 AGM	28 Nov 2017
Change in substantial holding	14 Nov 2017
Net Tangible Asset Backing – 31 October 2017	1 Nov 2017
Appendix 3B	27 Oct 2017
Notice of Annual General Meeting/Proxy Form	6 Oct 2017
Net Tangible Asset Backing – 30 September 2017	2 Oct 2017
Appendix 4G 30 June 2017	14 Sep 2017
Annual Report to Shareholders 30 June 2017	14 Sep 2017
BioImpact Extends License Agreement with RLS Global	13 Sep 2017
Net Tangible Asset Backing – 31 August 2017	4 Sep 2017
Appendix 4E and Financial Report 30 June 2017	29 Aug 2017
Change in substantial holding	22 Aug 2017
Net Tangible Asset Backing – 31 July 2017	1 Aug 2017
Change in substantial holding	1 Aug 2017
Biotech Capital to trade as BTC Health	24 Jul 2017
Net Tangible Asset Backing – 30 June 2017	4 Jul 2017
Change in substantial holding	13 Jun 2017
Net Tangible Asset Backing – 31 May 2017	1 Jun 2017
BioImpact enters into License Agreement with RLS Global	5 May 2017
Net Tangible Asset Backing – 30 April 2017	1 May 2017
Net Tangible Asset Backing – 31 March 2017	5 Apr 2017
Change in substantial holding	20 Mar 2017
Biointelect Appoints Senior Clinical Services Executive	14 Mar 2017
Change in substantial holding – Windarri Investments	9 Mar 2017
Change of Director’s Interest Notice – Peter Jones	8 Mar 2017
Change of Director’s Interest Notice – Richard Treagus	8 Mar 2017
Cleansing Notice	8 Mar 2017
Appendix 3B	8 Mar 2017
Share Purchase Plan Completion	8 Mar 2017
Net Tangible Asset Backing – 28 February 2017	2 Mar 2017
Appointment of Senior Business Development Executive	27 Feb 2017
Half Yearly Report and Accounts – 31 December 2016	24 Feb 2017
Change in substantial holding	24 Feb 2017
Change in substantial holding – Richard Treagus	23 Feb 2017
Change in substantial holding – Peter Jones	23 Feb 2017
BioImpact Appoints Senior In-Licensing Executive	23 Feb 2017
Private Placement – Cleansing Notice	22 Feb 2017
Appendix 3B	22 Feb 2017
Share Purchase Plan	14 Feb 2017
Share Purchase Plan – Cleansing Notice	14 Feb 2017
Completion of Capital Raise	14 Feb 2017
Trading Halt	13 Feb 2017
Investor Presentation – 10 February 2017	10 Feb 2017
Net Tangible Asset Backing – 31 January 17	2 Feb 2017
Becoming a substantial holder	31 Jan 2017
Change of Share Register Notification	13 Jan 2017
Net Tangible Asset Backing – 31 December 16	3 Jan 2017

DOCUMENT	RELEASED
Notice in accordance with Listing Rule 3.16	15 Dec 2016
Net Tangible Asset Backing – 30 November 16	6 Dec 2016
Results of Annual General Meeting 29 November 2016	29 Nov 2016
Chairman’s Address to Shareholders 2016 AGM	29 Nov 2016
Strategic Alliance with Industry Expert in San Diego, USA	21 Nov 2016
Net Tangible Asset Backing – 31 October 2016-BTC.AX	1 Nov 2016
Notice of Annual General Meeting/Proxy Form-BTC.AX	27 Oct 2016
Change of Director’s Interest Notice – Jennifer Herz-BTC.AX	27 Oct 2016
Change of Director’s Interest Notice – Richard Treagus-BTC.AX	27 Oct 2016
Appendix 4G 30 June 2016-BTC.AX	25 Oct 2016
Annual Report to Shareholders 30 June 2016-BTC.AX	25 Oct 2016
Net Tangible Asset Backing – 30 September 2016-BTC.AX	11 Oct 2016
Financial Statements and Directors Report – 30 June 2016-BTC.AX	7 Sep 2016
Net Tangible Asset Backing – 31 August 2016-BTC.AX	1 Sep 2016
Appendix 4E – 30 June 2016-BTC.AX	30 Aug 2016
Net Tangible Asset Backing – 31 July 2016-BTC.AX	12 Aug 2016
Biotech Capital invests in bio101Group-BTC.AX	4 Jul 2016
Net Tangible Asset Backing – 30 June 2016-BTC.AX	4 Jul 2016
Net Tangible Asset Backing – 31 May 2016-BTC.AX	1 Jun 2016
Investor Presentation 18/05/2016-BTC.AX	18 May 2016
Net Tangible Asset Backing – 30 April 2016-BTC.AX	2 May 2016
Ceasing to be a substantial holder-BTC.AX	21 Apr 2016
Change in substantial holding-BTC.AX	6 Apr 2016
Change in substantial holding-BTC.AX	6 Apr 2016
Change in substantial holding – Richard Treagus-BTC.AX	5 Apr 2016
Change in substantial holding – Peter Jones-BTC.AX	5 Apr 2016
Change of Director’s Interest Notice – Peter Jones-BTC.AX	5 Apr 2016
Becoming a substantial holder – Windarri Investments-BTC.AX	5 Apr 2016
Initial Director’s Interest Notice – Jennifer Herz-BTC.AX	5 Apr 2016
Appendix 3B-BTC.AX	5 Apr 2016
Strategic Acquisition of Biointelect-BTC.AX	4 Apr 2016
Net Tangible Asset Backing – 31 March 2016	1 Apr 2016
Becoming a substantial holder	16 Mar 2016
Net Tangible Asset Backing – 29 February 2016	1 Mar 2016
Half Yearly Report and Accounts	24 Feb 2016
Share trading policy	23 Feb 2016
Net Tangible Asset Backing 31 January 2016	1 Feb 2016
Net Tangible Asset Backing 31 December 2015	4 Jan 2016

DOCUMENT	RELEASED
Net Tangible Asset Backing 31 May 2014	2 Jun 2014
Net Tangible Asset Backing 30 April 2014	1 May 2014
Update of Share Registry Address April 2014	22 Apr 2014
Net Tangible Asset Backing 31 March 2014	1 Apr 2014
Ceasing to be a substantial holder	21 Mar 2014
Becoming a substantial holder – DDC	21 Mar 2014
Response to ASX price query	20 Mar 2014
Becoming a substantial holder	5 Mar 2014
Net Tangible Asset Backing 28 February 2014	4 Mar 2014
Half Yearly Report and Accounts 31 December 2013	21 Feb 2014
Net Tangible Asset Backing 31 January 2014	3 Feb 2014
Net Tangible Asset Backing 31 December 2013	2 Jan 2014

DOCUMENT	RELEASED
Net Tangible Asset Backing 30 November 2013	3 Dec 2013
Results of Annual General Meeting 19 November 2013	19 Nov 2013
Chairman’s Address to Shareholders 2013 AGM	19 Nov 2013
Change in substantial holding	8 Nov 2013
Change in substantial holding	1 Nov 2013
Net Tangible Asset Backing 31 October 2013	1 Nov 2013
Change in substantial holding	22 Oct 2013
Proxy Form 2013	15 Oct 2013
Notice of Annual General Meeting 2013	15 Oct 2013
Net Tangible Asset Backing 30 September 2013	1 Oct 2013
Annual Report to Shareholders 30 June 2013	20 Sep 2013
Net Tangible Asset Backing 31 August 2013	2 Sep 2013
Financial Report 30 June 2013	20 Aug 2013
Appendix 4E 30 June 2013	20 Aug 2013
Becoming a substantial holder	6 Aug 2013
Ceasing to be a substantial holder	2 Aug 2013
Net Tangible Asset Backing 31 July 2013	2 Aug 2013
Change in substantial holding	25 Jul 2013
Change in substantial holding	12 Jul 2013
Net Tangible Asset Backing 30 june 2013	1 Jul 2013
Net Tangible Asset Backing 31 May 2013	3 Jun 2013
Net Tangible Asset Backing 30 April 2013	1 May 2013
Response to ASX Query	11 Apr 2013
Net Tangible Asset Backing 28 February 2013	1 Mar 2013
Half Yearly Report and Accounts 31 December 2012	20 Feb 2013
Net Tangible Asset Backing 31 January 2013	1 Feb 2013
Net Tangible Asset Backing 31 December 2012	2 Jan 2013